acamprosatum 300 mg ut acamprosatum calcicum, crospovidonum, cellulosum microcristallinum, magnesii silicas, carboxymethylamylum natricum A corresp. natrium max. 0.42 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: acidi methacrylici et ethylis acrylatis polymerisatum 1:1, talcum, propylenglycolum pro compresso obducto.
Packungsbestandteile
magensaftresistente Filmtabletten
Active Agent
Dose
Acamprosatum
300 mg
BAG: Active Agent
Dose
Acamprosatum
300 mg
Inactive agents
additional_information
Acidi Methacrylici
Überzug
Carboxymethylamylum Natricum A
Cellulosum Microcristallinum
Crospovidonum
Ethylis Acrylatis Polymerisatum
Magnesii Silicas
Magnesii Stearas
Propylenglycolum pro Compresso Obducto
Silica Colloidalis Anhydrica
Talcum
Source
Data was imported : 05.03.2020
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
